Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

por Canal, Berta, McClure, Allison W., Curran, Joseph F., Wu, Mary, Ulferts, Rachel, Weissmann, Florian, Zeng, Jingkun, Bertolin, Agustina P., Milligan, Jennifer C., Basu, Souradeep, Drury, Lucy S., Deegan, Tom D., Fujisawa, Ryo, Roberts, Emma L., Basier, Clovis, Labib, Karim, Beale, Rupert, Howell, Michael, Diffley, John F.X.
Publicado 2021

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase

por Basu, Souradeep, Mak, Tiffany, Ulferts, Rachel, Wu, Mary, Deegan, Tom, Fujisawa, Ryo, Tan, Kang Wei, Lim, Chew Theng, Basier, Clovis, Canal, Berta, Curran, Joseph F., Drury, Lucy S., McClure, Allison W., Roberts, Emma L., Weissmann, Florian, Zeisner, Theresa U., Beale, Rupert, Cowling, Victoria H., Howell, Michael, Labib, Karim, Diffley, John F.X.
Publicado 2021

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease

por Milligan, Jennifer C., Zeisner, Theresa U., Papageorgiou, George, Joshi, Dhira, Soudy, Christelle, Ulferts, Rachel, Wu, Mary, Lim, Chew Theng, Tan, Kang Wei, Weissmann, Florian, Canal, Berta, Fujisawa, Ryo, Deegan, Tom, Nagaraj, Hema, Bineva-Todd, Ganka, Basier, Clovis, Curran, Joseph F., Howell, Michael, Beale, Rupert, Labib, Karim, O'Reilly, Nicola, Diffley, John F.X.
Publicado 2021